Inhibition of cytomegalovirus infection and photothermolysis of infected cells using bioconjugated gold nanoparticles

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Derussy, Bernadette M ^a   Aylward, Madeline A ^a   Fan, Zhen ^b   Ray, Paresh C ^b   Tandon, Ritesh ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b JACKSON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GOLD; METAL NANOPARTICLE; MONOCLONAL ANTIBODY; NANOCONJUGATE; PHOTOSENSITIZING AGENT;

CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG EFFECTS; DRUG SCREENING; HUMAN; IMMUNOLOGY; RADIATION RESPONSE; TISSUE TRANSPLANTATION; VIRUS ENTRY;

ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG EVALUATION, PRECLINICAL; GOLD; HUMANS; METAL NANOPARTICLES; NANOCONJUGATES; PHOTOSENSITIZING AGENTS; TISSUE TRANSPLANTATION; VIRUS INTERNALIZATION;

EID: 84903975948     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05550     Document Type: Article

References (30)

1. Krause, P. R. et al. Priorities for CMV vaccine development. Vaccine 32, 4-10 (2013).
2. Hakki, M. & Chou, S. The biology of cytomegalovirus drug resistance. Curr. Opin. Infect. Dis. 24, 605-611 (2011).
3. Solanki, K. et al. Enzyme-based listericidal nanocomposites. Sci Rep 3, 1584 (2013).
4. Fan, Z. et al. Multifunctional plasmonic shell-magnetic core nanoparticles for targeted diagnostics, isolation, and photothermal destruction of tumor cells. ACS nano 6, 1065-1073 (2012).
5. Fan, Z. et al. Popcorn-shaped magnetic core-plasmonic shell multifunctional nanoparticles for the targeted magnetic separation and enrichment, label-free SERS imaging, and photothermal destruction of multidrug-resistant bacteria. Chem. Eur. J. 19, 2839-2847 (2013).
6. Shen, S. et al. CMCTS stabilized Fe3O4 particles with extremely low toxicity as highly efficient near-infrared photothermal agents for in vivo tumor ablation. Nanoscale 5, 8056-8066 (2013).
7. Singh, A. K. et al. Gold Nanorod Based Selective Identification of Escherichia coli Bacteria Using Two-Photon Rayleigh Scattering Spectroscopy. ACS nano 3, 1906-1912 (2009).
8. Zharov, V. P., Mercer, K. E., Galitovskaya, E. N. & Smeltzer, M. S. Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. Biophys. J. 90, 619-627 (2006).
9. Cabral, H., Nishiyama, N. & Kataoka, K. Supramolecular nanodevices: from design validation to theranostic nanomedicine. Acc. Chem. Res. 44, 999-1008 (2011).
10. Dreaden, E. C., Mackey, M. A., Huang, X., Kang, B. & El-Sayed, M. A. Beating cancer in multiple ways using nanogold. Chem Soc Rev 40, 3391-3404 (2011).
11. Ganta, S. & Amiji, M. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol. Pharm. 6, 928-939 (2009).
12. Lane, D. Designer combination therapy for cancer. Nat. Biotechnol. 24, 163-164 (2006). (Pubitemid 43224239)
13. Wang, S. et al. Multifunctional biodegradable polyacrylamide nanocarriers for cancer theranostics-a "see and treat" strategy. ACS nano 6, 6843-6851 (2012).
14. Griffin, J. et al. Sequence-specific HCV RNA quantification using the sizedependent nonlinear optical properties of gold nanoparticles. Small 5, 839-845 (2009).
15. Fan, Z., Senapati, D., Singh, A. K. & Ray, P. C. Theranostic magnetic coreplasmonic shell star shape nanoparticle for the isolation of targeted rare tumor cells from whole blood, fluorescence imaging, and photothermal destruction of cancer. Mol. Pharm. 10, 857-866 (2013).
16. Beqa, L., Fan, Z., Singh, A. K., Senapati, D. & Ray, P. C. Gold nano-popcorn attached SWCNT hybrid nanomaterial for targeted diagnosis and photothermal therapy of human breast cancer cells. ACS Appl Mater Interfaces 3, 3316-3324 (2011).
17. Khan, S. A., Singh, A. K., Senapati, D., Fan, Z. & Ray, P. C. Targeted highly sensitive detection of multi-drug resistant Salmonella DT104 using gold nanoparticles. Chem. Commun. (Camb.) 47, 9444-9446 (2011).
18. Moorman, N. J., Sharon-Friling, R., Shenk, T. & Cristea, I. M. A targeted spatialtemporal proteomics approach implicates multiple cellular trafficking pathways in human cytomegalovirus virion maturation. Mol. Cell Proteomics 9, 851-860 (2010).
19. Murphy, E. et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 100, 14976-14981 (2003). (Pubitemid 37518002)
20. Ades, E. W. et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99, 683-690 (1992). (Pubitemid 23002027)
21. Mocarski, E. S., Jr., Shenk, T. & Pass, R. F. Cytomegaloviruses. p. 2701-2772. In Knipe, D. M. & Howley, P. M. (ed.), Fields Virology. 5th Edition. Lippincott Williams & Wilkins, Philadelphia. (2006).
22. Lu, W. et al. Gold nano-popcorn-based targeted diagnosis, nanotherapy treatment, and in situ monitoring of photothermal therapy response of prostate cancer cells using surface-enhanced Raman spectroscopy. J. Am. Chem. Soc. 132, 18103-18114 (2010).
23. Senapati, D., Singh, A. K., Khan, S. A., Senapati, T. & Ray, P. C. Probing real time gold nanostar formation process using two-photon scattering spectroscopy. Chem Phys Lett 504, 46-51 (2011).
24. Ray, P. C., Khan, S. A., Singh, A. K., Senapati, D. & Fan, Z. Nanomaterials for targeted detection and photothermal killing of bacteria. Chem Soc Rev 41, 3193-3209 (2012).
25. Yu, D., Silva, M. C. & Shenk, T. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. U.S.A. 100, 12396-12401 (2003). (Pubitemid 37271571)
26. Dunn, W. et al. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U.S.A. 100, 14223-14228 (2003). (Pubitemid 37499218)
27. Gibson, W. Protein counterparts of human and simian cytomegaloviruses. Virology 128, 391-406 (1983).
28. Irmiere, A. & Gibson, W. Isolation of human cytomegalovirus intranuclear capsids, characterization of their protein constituents, and demonstration that the B-capsid assembly protein is also abundant in noninfectious enveloped particles. J. Virol. 56, 277-283 (1985). (Pubitemid 16214112)
29. Thomsen, D. R., Newcomb, W. W., Brown, J. C. & Homa, F. L. Assembly of the herpes simplex virus capsid: requirement for the carboxyl-terminal twenty-five amino acids of the proteins encoded by the UL26 and UL26.5 genes. J. Virol. 69, 3690-3703 (1995).
30. Tandon, R. &Mocarski, E. S. Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids. J. Virol. 85, 7129-7141 (2011).